Counterfeited “CRESTOR” detected in Mexico
Employers of pharmacies in Mexico have been warned about the counterfeiting of CRESTOR, a drug for the prevention of cardiovascular diseases manufactured by AstraZeneca Laboratories.
The medicine involved is “CRESTOR” 10 mg in a presentation of 30 tablets. The packaging has been falsified for introducing expired medications in the hopes of reselling the expired tablets.
The commercial director of the National Association of Pharmacies of Mexico reported that all the expired drugs have been already removed from pharmacies.
On March 22, 2016 the Federal Commission for the Protection against Sanitary Risk has issued a public warning detailing the irregularities.
It has been recommended the population not purchase or use this product, as it may create a health risk. If someone has purchased or even used the product recently they should notify the Commission immediately at 018000335050.
While the original packaging describes the batch L 71456 and expiration date MAR 18, the fake version indicates the batch L 71456 and expiration date C ENE 18 (translated JAN 18).
In addition, the seal of the blister does not indicate the dosage or unit of the medicine (5 mg, 10 mg, 20 mg, or 40 mg).
Due to expert counterfeiting measures, no one was certain of the real integrity and consequent effectiveness of the medication.
Crestor is a drug which is indicated for primary prevention of cardiovascular diseases, due to the fact that it reduces the risk of cardiovascular accidents, the risk of myocardial infarctions, the risk of revascularization procedures; and also to reduce total cholesterol, LDL-C, Apo B, non-HDL cholesterol and triglycerides and helps for increasing HDL-C.
Upon being notified of the existence of their product’s packaging being counterfeited, AstraZeneca Laboratories called for an immediate removal of the expired products from the shelves of Mexican pharmacies.